(Q44000013)

28 November 2017

title

Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure (English)

1 reference

28 November 2017

0 references

2

Torbjørn Omland

1 reference

28 November 2017

8

Jean-Lucien Rouleau

1 reference

28 November 2017

Wendy Johnson

1

1 reference

28 November 2017

Christian Hall

3

1 reference

28 November 2017

Caroline Lucas

4

1 reference

28 November 2017

Ole L Myking

5

1 reference

28 November 2017

Caroline Collins

6

1 reference

28 November 2017

Marc Pfeffer

7

1 reference

28 November 2017

Lynne W Stevenson

9

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Journal of the American College of Cardiology

28 November 2017

published in

1 reference

28 November 2017

volume

39

1 reference

28 November 2017

issue

10

1 reference

28 November 2017

page(s)

1623-1629

1 reference

Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction. SOLVD Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : the randomized evaluation of strategies for left ventricular dysfunction pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Effect of the Implantable Left Ventricular Assist Device on Neuroendocrine Activation in Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Plasma norepinephrine in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Isolated ultrafiltration in moderate congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Plasma endothelin in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Down-regulation of ET(B) receptor, but not ET(A) receptor, in congestive lung secondary to heart failure. Are marked increases in circulating endothelin-1 partly attributable to decreases in lung ET(B) receptor-mediated clearance of endothelin-1?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Endothelins. Myocardial actions of a new class of cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Integrated cardiac, renal, and endocrine actions of endothelin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Endothelin stimulates release of atrial natriuretic peptides in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Pulmonary release and coronary and peripheral consumption of big endothelin and endothelin-1 in severe heart failure: acute effects of vasodilator therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Atrial natriuretic peptide elevation in congestive heart failure in the human

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Responsiveness of atrial natriuretic factor to reduction in right atrial pressure in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Effect of atrial natriuretic peptide (8-33-Met ANP) in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

10.1016/S0735-1097(02)01814-4

Identifiers

DOI

1 reference

28 November 2017

1 reference